KR890014101A - 동맥경화증 치료제 - Google Patents
동맥경화증 치료제 Download PDFInfo
- Publication number
- KR890014101A KR890014101A KR1019890003642A KR890003642A KR890014101A KR 890014101 A KR890014101 A KR 890014101A KR 1019890003642 A KR1019890003642 A KR 1019890003642A KR 890003642 A KR890003642 A KR 890003642A KR 890014101 A KR890014101 A KR 890014101A
- Authority
- KR
- South Korea
- Prior art keywords
- atherosclerosis treatment
- group
- atherosclerosis
- treatment
- integers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 201000001320 Atherosclerosis Diseases 0.000 title claims 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 125000002883 imidazolyl group Chemical group 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 125000000335 thiazolyl group Chemical group 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (1)
- 활성성분으로서 일반식(I) 의 화합물 또는 이의 염을 함유하는 동맥경화증 치료제.상기식에서, R은 이미다졸일 그룹, 티아졸일 그룹, 또는 피리딜 그룹을 나타내고, n은 1또는 2를 나타내며, m은 1내지 4중 한 정수를 나탄낸다.※ 참고사항:최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7045388 | 1988-03-24 | ||
JP63-70453 | 1988-03-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR890014101A true KR890014101A (ko) | 1989-10-21 |
Family
ID=13431941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019890003642A Ceased KR890014101A (ko) | 1988-03-24 | 1989-03-23 | 동맥경화증 치료제 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0334369B1 (ko) |
KR (1) | KR890014101A (ko) |
AU (1) | AU614589B2 (ko) |
CA (1) | CA1334380C (ko) |
DE (1) | DE68907244T2 (ko) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2657058B1 (fr) * | 1990-01-18 | 1994-10-21 | Peugeot | Dispositif de commande manuelle du frein de stationnement d'un vehicule automobile. |
-
1989
- 1989-03-23 AU AU31712/89A patent/AU614589B2/en not_active Ceased
- 1989-03-23 CA CA000594688A patent/CA1334380C/en not_active Expired - Fee Related
- 1989-03-23 EP EP89105270A patent/EP0334369B1/en not_active Expired - Lifetime
- 1989-03-23 DE DE89105270T patent/DE68907244T2/de not_active Expired - Fee Related
- 1989-03-23 KR KR1019890003642A patent/KR890014101A/ko not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
AU614589B2 (en) | 1991-09-05 |
AU3171289A (en) | 1989-09-28 |
DE68907244T2 (de) | 1993-10-07 |
EP0334369A2 (en) | 1989-09-27 |
DE68907244D1 (de) | 1993-07-29 |
EP0334369B1 (en) | 1993-06-23 |
CA1334380C (en) | 1995-02-14 |
EP0334369A3 (en) | 1990-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE100802T1 (de) | Stabilisierte waessrige loesungen von 3isothiazolinonen. | |
DE3783683D1 (de) | Hautpenetration verbessernde zusammensetzungen. | |
KR910004187A (ko) | 세트랄린을 사용한 조기사정의 치료방법 | |
KR890008086A (ko) | 사이클로헥산 유도체 | |
KR960006915A (ko) | 췌장염의 치료 조성물 | |
KR900002700A (ko) | 살균제 조성물 | |
KR870005968A (ko) | 아미드 유도체 및 이를 함유하는 외용약제 | |
KR900001715A (ko) | Bu-3608 유도체 | |
KR890003752A (ko) | 2-피리미디닐-피페라딘 유도체의 용도 | |
KR910021361A (ko) | 항궤양 물질 | |
KR890001540A (ko) | 심부전증 치료제 | |
KR890014101A (ko) | 동맥경화증 치료제 | |
KR890001543A (ko) | 당뇨병 치료제 | |
KR900701262A (ko) | 췌장염 등에 대한 치료제 | |
KR960702458A (ko) | 퀴놀린 유도체 또는 그의 염 및 이를 함유 하는 항균제 | |
KR910000148A (ko) | 말초순환 장애용 치료제 | |
KR890016027A (ko) | 벤즈티아졸 살진균제 | |
KR890009270A (ko) | 식물 보호용 살균제 | |
KR910000115A (ko) | 멜라닌 생성 억제 외용제 | |
KR920019349A (ko) | 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도 | |
KR920016021A (ko) | 동물의 발육 촉진 또는 개선 사료 및 방법 | |
KR900003201A (ko) | 펩티드 및 항치매제 | |
KR900016130A (ko) | 2-피리딜메틸티오 유도체 및 궤양 치료제 | |
KR900001368A (ko) | 후천성 면역 결핍증의 예방 및 치료제 | |
KR920000327A (ko) | 비스(3,5-디-알킬-4- 히드록시페닐티오) 메탄을 유효 성분으로 함유하는 고트리글리세리드혈증 치료용 제약 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19890323 |
|
PG1501 | Laying open of application | ||
A201 | Request for examination | ||
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 19940321 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 19890323 Comment text: Patent Application |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 19970718 Patent event code: PE09021S01D |
|
E601 | Decision to refuse application | ||
PE0601 | Decision on rejection of patent |
Patent event date: 19971021 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 19970718 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |